Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/39475
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrown A.J.en
dc.contributor.authorIhdayhid A.-R.en
dc.contributor.authorMcCormick L.M.en
dc.contributor.authorCameron J.D.en
dc.contributor.authorBennett M.R.en
dc.contributor.authorMalaiapan Y.en
dc.contributor.authorMeredith I.T.en
dc.contributor.authorNerlekar N.en
dc.contributor.authorCheshire C.J.en
dc.contributor.authorVerma K.P.en
dc.date.accessioned2021-05-14T13:28:24Zen
dc.date.available2021-05-14T13:28:24Zen
dc.date.copyright2017en
dc.date.created20170410en
dc.date.issued2017-04-10en
dc.identifier.citationEuroIntervention. 12 (13) (pp 1632-1642), 2017. Date of Publication: 2017.en
dc.identifier.issn1774-024Xen
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/39475en
dc.description.abstractAims: Our aim was to assess whether intravascular ultrasound (IVUS) improves clinical outcomes during implantation of first-and second-generation drug-eluting stents (DES). IVUS guidance is associated with improved clinical outcomes during DES implantation, but it is unknown whether this benefit is limited to either first-or second-generation devices. Methods and Results: MEDLINE, EMBASE and PubMed were searched for studies comparing outcomes between IVUS-and angiography-guided PCI. Among 909 potentially relevant studies, 15 trials met the inclusion criteria. The primary endpoint was MACE, defined as death, myocardial infarction, target vessel/ lesion revascularisation (TVR/TLR) or stent thrombosis (ST). Summary estimates were obtained using Peto modelling. In total, 9,313 patients from six randomised trials and nine observational studies were included. First-generation DES were implanted in 6,156 patients (3,064 IVUS-guided and 3,092 angiography-guided) and second-generation in 3,157 patients (1,528 IVUS-guided and 1,629 angiography-guided). IVUS guidance was associated with a significant reduction in MACE (odds ratio [OR] 0.73, 95% CI: 0.64-0.85, p<0.001), across both first-(OR 0.79, 95% CI: 0.67-0.92, p=0.01) and second-generation DES (0.57, 95% CI: 0.43-0.77, p<0.001). For second-generation DES, IVUS guidance was associated with significantly lower rates of cardiac death (OR 0.33, 95% CI: 0.14-0.78, p=0.02), TVR (OR 0.47, 95% CI: 0.28-0.79, p=0.006), TLR (OR 0.61, 95% CI: 0.42-0.90, p=0.01) and ST (OR 0.31, 95% CI: 0.12-0.78, p=0.02). Cumulative meta-analysis highlighted progressive temporal benefit towards IVUS-guided PCI to reduce MACE (OR 0.60, 95% CI: 0.48-0.75, p<0.001). Conclusion(s): IVUS guidance is associated with a significant reduction in MACE during implantation of both first-and second-generation DES platforms. These data support the use of IVUS guidance in contemporary revascularisation procedures using second-generation DES.Copyright © Europa Digital & Publishing 2017. All rights reserved.en
dc.languageenen
dc.languageEnglishen
dc.publisherEuroPCRen
dc.relation.ispartofEuroInterventionen
dc.titleIntravascular ultrasound guidance improves clinical outcomes during implantation of both first-and secondgeneration drug-eluting stents: A meta-analysis.en
dc.typeArticleen
dc.type.studyortrialSystematic review and/or meta-analysis-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.4244/EIJ-D-16-00769en
dc.publisher.placeFranceen
dc.identifier.pubmedid27840327 [http://www.ncbi.nlm.nih.gov/pubmed/?term=27840327]en
dc.identifier.source614990959en
dc.identifier.institution(Nerlekar, Cheshire, Verma, Ihdayhid, McCormick, Cameron, Malaiapan, Meredith, Brown) Monash Cardiovascular Research Centre and MonashHeart, Monash Health, Clayton, VIC 3168, Australia (Bennett, Brown) Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdomen
dc.description.addressA.J. Brown, Monash Cardiovascular Research Centre and MonashHeart, Monash Health, Clayton, VIC 3168, Australia. E-mail: ajdbrown@me.comen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2017 Elsevier B.V., All rights reserved.en
dc.subect.keywordsCoronary angioplasty Drug-eluting stent Intravascular ultrasound Meta-analysis Percutaneous coronary interventionen
dc.identifier.authoremailBrown A.J.; ajdbrown@me.comen
dc.identifier.affiliationext(Bennett, Brown) Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom-
dc.identifier.affiliationmh(Nerlekar, Cheshire, Verma, Ihdayhid, McCormick, Cameron, Malaiapan, Meredith, Brown) Monash Cardiovascular Research Centre and MonashHeart, Monash Health, Clayton, VIC 3168, Australia-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
crisitem.author.deptCardiology (MonashHeart & Victorian Heart Institute)-
crisitem.author.deptCardiology (MonashHeart & Victorian Heart Institute)-
Appears in Collections:Articles
Show simple item record

Page view(s)

22
checked on Sep 11, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.